Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00790517 · ClinicalTrials.gov registry record · Phase 2
Reducing Weight and Diabetes Risk in an Underserved Population (STRIDE)
A Phase 2 study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- Phase 2
- Development phase
- 200
- Enrollment target
NCT00790517: Completed Phase 2 study, sponsored by Kaiser Permanente.
NCT00790517 is a Phase 2 study that has completed, run by Kaiser Permanente. The registered enrollment target is 200 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (50% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00790517, a Phase 2 study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 200 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effectiveness of a lifestyle intervention designed to reduce weight and diabetes risk in a population of individuals with mental illness who are also taking antipsychotic medications. We will examine the effectiveness of the intervention in 1. reducing weight and Body Mass Index; 2. reducing fasting insulin levels and increasing insulin sensitivity; and 3. reducing total cholesterol and LDL cholesterol.
Interventions
- BEHAVIORAL Premier Lifestyle Intervention with DASH Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2009-06 |
| Est. Completion | 2014-12 |
| Phase | Phase 2 |
What the finished NCT00790517 record still lists
NCT00790517 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (50% higher).
The record links to 0 conditions, and to 1 intervention - of which Premier Lifestyle Intervention with DASH Diet is the first listed.
NCT00790517 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00790517 about?
NCT00790517 is a clinical study titled "Reducing Weight and Diabetes Risk in an Underserved Population (STRIDE)". The purpose of this study is to examine the effectiveness of a lifestyle intervention designed to reduce weight and diabetes risk in a population of individuals with mental illness who are also taking antipsychotic medications. We will examine the effectiveness of the intervention in 1. reducing we...
What is the current status of trial NCT00790517?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2009-06. Estimated completion is 2014-12.
What interventions are being tested in trial NCT00790517?
The interventions under investigation include: Premier Lifestyle Intervention with DASH Diet (BEHAVIORAL).
Who is sponsoring clinical trial NCT00790517?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00790517's enrollment target sits among peer trials
200 304th of 2000 higher than 1,652 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia